PROMISE Substudy Results, Published in the American Heart Journal, Provide Independent Validation of the Clinical Value of the Corus(R) CAD Blood Test to Accurately Identify Patients with Obstructive CAD
February 06, 2017 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Feb 6, 2017) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the publication of a peer-reviewed substudy...
CardioDx Announces Final Endpoint Results from the PRESET Registry at the AHA Scientific Sessions 2016
November 14, 2016 08:30 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Nov 14, 2016) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced results from the final endpoint analysis...
Motif Bio Files Registration Statement for Proposed U.S. Public Offering of American Depositary Shares and Applies for NASDAQ Listing
July 13, 2016 02:00 ET
|
Motif Bio
LONDON, UNITED KINGDOM--(Marketwired - Jul 13, 2016) - Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it has...
Khush F. Mehta Joins CardioDx as Chief Executive Officer
June 01, 2016 08:30 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Jun 1, 2016) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the appointment of Khush Mehta as President,...
New Data Demonstrate That WATS3D Is 4X More Effective Than the Seattle Random Biopsy Protocol in the Detection of High-Grade Dysplasia and Esophageal Adenocarcinoma
May 21, 2016 12:00 ET
|
CDx Diagnostics
SUFFERN, NY--(Marketwired - May 21, 2016) - CDx Diagnostics today announced final data from a multicenter, prospective, randomized, crossover study demonstrating a fourfold increase in the detection...
Renew Medical Launches New Solution to Help Prevent Accidental Bowel Leakage
May 18, 2016 09:00 ET
|
Renew Medical
FOSTER CITY, CA--(Marketwired - May 18, 2016) - Renew Medical Inc. (Renew) announced today the U.S. launch of the Renew Insert, an innovative silicone rectal insert device now available by...
CDx Diagnostics to Unveil New Data Demonstrating a Significant Advance in the Prevention of the Most Rapidly Growing Cancer in the U.S.
May 17, 2016 09:00 ET
|
CDx Diagnostics
SUFFERN, NY--(Marketwired - May 17, 2016) - CDx Diagnostics today announced that results from a multi-center, prospective, randomized clinical trial demonstrating that WATS3D (Wide Area...
PROMISE Trial Substudy Demonstrates That the Corus CAD Blood Test Is Associated With Clinical Events Among Patients Being Evaluated for Suspected Obstructive Coronary Artery Disease
April 04, 2016 08:30 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Apr 4, 2016) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a genomic substudy of the...
Commentary in The American Journal of Medicine Reinforces the Value of the Corus CAD Test in Evaluating Symptomatic Patients With Suspected Obstructive Coronary Artery Disease
March 02, 2016 08:30 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Mar 2, 2016) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today that a Commentary entitled A Novel...
Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer
December 14, 2015 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Dec 14, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the appointment of Timothy Henn as Chief...